Trend in the use of drug eluting stents in the United States
- 1 July 2014
- journal article
- Published by Elsevier in International Journal of Cardiology
- Vol. 175 (1) , 108-119
Abstract
No abstract availableKeywords
Funding Information
- New York University School of Medicine
This publication has 21 references indexed in Scilit:
- Bare metal stents, durable polymer drug eluting stents, and biodegradable polymer drug eluting stents for coronary artery disease: mixed treatment comparison meta-analysisBMJ, 2013
- Everolimus-eluting stent versus bare-metal stent in ST-segment elevation myocardial infarction (EXAMINATION): 1 year results of a randomised controlled trialThe Lancet, 2012
- Outcomes with various drug eluting or bare metal stents in patients with diabetes mellitus: mixed treatment comparison analysis of 22 844 patient years of follow-up from randomised trialsBMJ, 2012
- Short- and Long-Term Outcomes With Drug-Eluting and Bare-Metal Coronary StentsCirculation, 2012
- Drug-Eluting vs Bare-Metal Stents in Primary AngioplastyArchives of internal medicine (1960), 2012
- A Cause for ConcernCirculation, 2007
- Long-Term Outcomes with Drug-Eluting Stents versus Bare-Metal Stents in SwedenNew England Journal of Medicine, 2007
- A Polymer-Based, Paclitaxel-Eluting Stent in Patients with Coronary Artery DiseaseNew England Journal of Medicine, 2004
- Sirolimus-Eluting Stents versus Standard Stents in Patients with Stenosis in a Native Coronary ArteryNew England Journal of Medicine, 2003
- Intravascular Stents to Prevent Occlusion and Re-Stenosis after Transluminal AngioplastyNew England Journal of Medicine, 1987